Tags

Type your tag names separated by a space and hit enter

Hepatitis A.
Infect Dis Clin North Am 2000; 14(3):605-15ID

Abstract

Hepatitis A remains an important cause of community-acquired hepatitis in the United States and in the world. In recent years, improvements in personal hygiene and environmental sanitation have led to declines in overall hepatitis A infection rates in developed countries, although sporadic outbreaks still occur with similar rates of hospitalization and loss of work. Therapy remains supportive and prevention holds the key to elimination of widespread infection. Acute infection can be prevented or attenuated with IG or with inactivated, highly immunogenic vaccines. Elderly persons and those with advanced liver disease are at higher risk of the consequences of acute HAV, and they represent target populations for immediate vaccination. Challenges for the future include strategies for broad-based population vaccination, including cost-effective approaches.

Authors+Show Affiliations

Department of Internal Medicine, University of Texas Medical Branch, Galveston, USA.No affiliation info available

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

10987112

Citation

Kemmer, N M., and E P. Miskovsky. "Hepatitis A." Infectious Disease Clinics of North America, vol. 14, no. 3, 2000, pp. 605-15.
Kemmer NM, Miskovsky EP. Hepatitis A. Infect Dis Clin North Am. 2000;14(3):605-15.
Kemmer, N. M., & Miskovsky, E. P. (2000). Hepatitis A. Infectious Disease Clinics of North America, 14(3), pp. 605-15.
Kemmer NM, Miskovsky EP. Hepatitis A. Infect Dis Clin North Am. 2000;14(3):605-15. PubMed PMID: 10987112.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Hepatitis A. AU - Kemmer,N M, AU - Miskovsky,E P, PY - 2000/9/15/pubmed PY - 2001/3/3/medline PY - 2000/9/15/entrez SP - 605 EP - 15 JF - Infectious disease clinics of North America JO - Infect. Dis. Clin. North Am. VL - 14 IS - 3 N2 - Hepatitis A remains an important cause of community-acquired hepatitis in the United States and in the world. In recent years, improvements in personal hygiene and environmental sanitation have led to declines in overall hepatitis A infection rates in developed countries, although sporadic outbreaks still occur with similar rates of hospitalization and loss of work. Therapy remains supportive and prevention holds the key to elimination of widespread infection. Acute infection can be prevented or attenuated with IG or with inactivated, highly immunogenic vaccines. Elderly persons and those with advanced liver disease are at higher risk of the consequences of acute HAV, and they represent target populations for immediate vaccination. Challenges for the future include strategies for broad-based population vaccination, including cost-effective approaches. SN - 0891-5520 UR - https://www.unboundmedicine.com/medline/citation/10987112/full_citation L2 - https://linkinghub.elsevier.com/retrieve/pii/S0891-5520(05)70123-9 DB - PRIME DP - Unbound Medicine ER -